Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Brief Reports

Effects of Depression on Work Loss and Disability Bed Days in Individuals With Diabetes

  1. Leonard E. Egede, MD, MS
  1. From the Department of Medicine and Center for Health Care Research, Medical University of South Carolina, Charleston, South Carolina
  1. Address correspondence and reprint requests to Leonard E. Egede, MD, Medical University of South Carolina, Department of Medicine and Center for Health Care Research, 135 Cannon St., Suite 403, P.O. Box 250837, Charleston, SC 29425. E-mail: egedel{at}musc.edu
Diabetes Care 2004 Jul; 27(7): 1751-1753. https://doi.org/10.2337/diacare.27.7.1751
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading
  • CIDI-SF, Composite International Diagnostic Interview Short Form
  • NHIS, National Health Interview Survey

Diabetes is highly prevalent in the U.S. and is associated with significant disability and increased health care costs (1–3). Depression is also highly prevalent and is a leading cause of disability, work place absenteeism, diminished or lost productivity, and increased use of health care resources (4,5). Coexisting depression occurs in 10–30% of people with diabetes, and people with diabetes have twofold increased odds of having depression compared with people without diabetes (6,7).

The objectives of this study were to determine 1) the effect of coexisting depression on mean work loss and disability bed days and 2) the effect of coexisting depression on odds of extended (defined as ≥7 days) work loss and disability bed days in individuals with and without diabetes. It was hypothesized that coexisting depression in people with diabetes would be associated with significant increases in mean disability days and odds of extended disability days.

RESEARCH DESIGN AND METHODS

Data from the sample adult core of 1999 National Health Interview Survey (NHIS) (8) were analyzed. The NHIS is a nationally representative household survey of U.S. adults aged ≥18 years. The sample is selected by a complex sampling design involving stratification, clustering, and multistage sampling, with a nonzero probability of selection for each person. Final weights allow estimates from the NHIS to be generalized to the adult civilian population of the U.S. (9).

Work loss days were defined as days in which a person missed work at a job or business because of illness or injury (2,3). Disability bed days were defined as days in which a person was kept in bed for more than one-half of the day due to illness or injury (2,3). Diagnosis of diabetes was based on self-report. Diagnosis of depression was based on the Composite International Diagnostic Interview Short Form (CIDI-SF). The CIDI-SF is a valid and reliable diagnostic interview and has classification accuracy of 93% for major depressive disorders (10). Details on CIDI-SF questions, the diagnostic algorithm, and scoring as used in the 1999 NHIS have been previously reported (7). Twelve-month prevalence estimates are reported.

A multilevel variable that defined four mutually exclusive disease categories was created. The four categories were diabetes alone, depression alone, both conditions, and neither condition. Additional comorbidity was defined as self-reported diagnosis of asthma, hypertension, coronary artery diseases, congestive heart failure, stroke, chronic obstructive pulmonary disease, cancer, end-stage renal disease, chronic liver disease, and chronic arthritis (rheumatoid arthritis, osteoarthritis, or arthritis due to gout) and were categorized as 0, 1, 2, or ≥3 conditions. Demographic variables included age, sex, race/ethnicity, education, employment, household income, census region, and BMI.

Statistical analysis was performed with Stata version 7.0 (11). Ordinary least-squares multiple regression equations were used to model work loss and disability bed days as a function of the four-level disease variable, controlling for age, sex, race/ethnicity, education, income, region, BMI, and number of chronic conditions. Adjusted least-square means were calculated for work loss and disability bed days for each disease category. Estimates for disability bed days were stratified by employment. Post hoc comparisons of adjusted means were performed and significance (P) values were adjusted with the Bonferroni method. In addition, multiple logistic regression was used to model the likelihood of extended (≥7) work loss and disability bed days as a function of the four-level disease variable, controlling for age, sex, race/ethnicity, education, income, region, BMI, number of chronic conditions, and employment (for disability bed days model only).

RESULTS

Of 30,801 adults who completed the 1999 NHIS, yielding a 70% response rate, 30,022 had complete data and were included in the analysis. Of these, 26,376 had neither condition, 1,852 had depression, 1,624 had diabetes, and 170 had both conditions. Table 1 shows adjusted mean work loss days and disability bed days (stratified by employment status). Post hoc comparisons (corrected with the Bonferroni method) showed that only the depression group significantly differed from neither condition. Mean disability bed days differed by employment status across the four disease categories. Post hoc comparisons showed that only the depression group differed from neither condition among the employed, whereas the depression and both condition groups differed from neither condition among the unemployed.

Table 2 shows the adjusted odds of extended (≥7) work loss or disability bed days by specific disorder. Individuals with depression (odds ratio [OR] 3.08, 95% CI 2.56–3.69), diabetes (1.50, 1.16–1.91), or both conditions (3.25, 1.69–6.23) had increased odds of having ≥7 work loss days compared with the reference group (individuals with neither condition). Similar results were seen for the adjusted odds of extended disability bed days: depression (4.00, 3.45–4.60), diabetes (1.63, 1.36–1.95), or both conditions (5.61, 3.62–8.69).

CONCLUSIONS

This study shows that coexisting depression in people with diabetes is associated with significant increases in mean disability bed days, especially among the unemployed. In addition, it shows that coexisting depression increases the odds of extended work loss and extended disability bed days in adults with diabetes. The results of this study build on the findings of an earlier study (12), which showed that coexisting depression had synergistic effects on odds of functional disability in people with diabetes. In combination, these studies show that coexisting depression in people with diabetes is associated with increased disability burden and lost productivity.

Work loss and disability bed days seem to capture different aspects of the burden of disability. Although work loss days capture the disability burden of only those with employment, disability bed days seem to capture the disability burden for both employed and unemployed individuals. Estimates of disability bed days stratified by employment (Table 2) status showed that both employed and unemployed individuals had disability bed days. However, the unemployed had significantly higher adjusted mean disability bed days. This finding suggests that estimates of disability burden that include both work loss and disability bed days are likely to give a more comprehensive picture of the overall burden of disability for any given condition. Limitations of this study include the inability to directly attribute disability days to the specified disease categories, unavailability of reliable data on chronic disease duration, disease severity, or comorbid psychiatric conditions, and inability to differentiate type 1 from type 2 diabetes.

View this table:
  • View inline
  • View popup
Table 1—

Adjusted mean work loss and disability bed days

View this table:
  • View inline
  • View popup
Table 2—

Adjusted odds of extended (≥7) work loss and disability bed days

Acknowledgments

L.E.E. is supported by grant no. 5K08HS11418 from the Agency for Health Care Research and Quality, Rockville, Maryland.

The anonymous reviewers’ suggestions for improving this manuscript are gratefully acknowledged.

This study was presented in part at the American Diabetes Association’s 63rd Scientific Sessions, New Orleans, Louisiana, 13–17 June 2003.

Footnotes

  • The contents of this publication are solely the responsibility of the author and do not necessarily represent the official views of the Agency for Health Care Research and Quality or the Centers for Disease Control and Prevention.

    A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • Accepted March 24, 2004.
    • Received March 23, 2004.
  • DIABETES CARE

References

  1. ↵
    National Institute of Diabetes and Digestive and Kidney Diseases: National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Bethesda, MD, U.S. Department of Health and Human Services, National Institutes of Health, 2003
  2. ↵
    Songer TJ: Disability in diabetes. In Diabetes in America. 2nd ed. Bethesda, MD, National Diabetes Data Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 1995, p. 259–282 (NIH publ. no. 95-1468)
  3. ↵
    American Diabetes Association: Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26:917–932, 2003
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, National Comorbidity Survey Replication: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095–3105, 2003
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    U.S. Department of Health and Human Services: Mental Health: A Report of the Surgeon General. Rockville, MD, U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health, 1999
  6. ↵
    Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078, 2001
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Egede LE, Zheng D: Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 26:104–111, 2003
    OpenUrlAbstract/FREE Full Text
  8. ↵
    National Center for Health Statistics: Dataset Documentation, National Health Interview Survey, 1999 [machine-readable data file and documentation]. Hyattsville, MD, National Center for Health Statistics, 2002
  9. ↵
    National Center for Health Statistics: NHIS Survey Description, National Health Interview Survey, 1999 [machine-readable documentation]. Hyattsville, MD, National Center for Health Statistics, 2002
  10. ↵
    Kessler RC, Andrews G, Mroczek D, Utsun TB, Wittchen HU: The World Health Organization’s Composite International Diagnostic Interview Short-Form (CIDI SF). Int J Methods Psychiatr Res 7:171–185, 1997
  11. ↵
    StataCorp: Stata Statistical Software: Release 7.0. College Station, TX, Stata, 2001
  12. ↵
    Egede LE: Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 27:421–428, 2004
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Diabetes Care: 27 (7)

In this Issue

July 2004, 27(7)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Depression on Work Loss and Disability Bed Days in Individuals With Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Effects of Depression on Work Loss and Disability Bed Days in Individuals With Diabetes
Leonard E. Egede
Diabetes Care Jul 2004, 27 (7) 1751-1753; DOI: 10.2337/diacare.27.7.1751

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Effects of Depression on Work Loss and Disability Bed Days in Individuals With Diabetes
Leonard E. Egede
Diabetes Care Jul 2004, 27 (7) 1751-1753; DOI: 10.2337/diacare.27.7.1751
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Combination Therapy With Fenofibrate and Rosiglitazone Paradoxically Lowers Serum HDL Cholesterol
  • β-Cell Transplantation Restores Metabolic Control and Quality of Life in a Patient With Subcutaneous Insulin Resistance
  • Hematocrit and the Incidence of Type 2 Diabetes in the Pima Indians
Show more Brief Reports

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.